Internal Medicine · Los Angeles, CA
NPI
1962707265
Since 2011
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1200 North State Street, Ird 620
Los Angeles, CA, 90031
Phone (909) 910-5246
Groups this clinician bills Medicare through
Medicare paid, 2022
$913
17 services
Medicare patients, 2022
12
Average age 56
Drug cost, 2024
$827K
3,134 prescriptions
Company payments, 2025
$221
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Anjali Jain prescribed most often to Medicare patients was Levothyroxine Sodium, with 387 prescriptions and refills. In total Anjali Jain wrote 3,134 Medicare prescriptions that cost $827K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-04.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 387 | 1,273 | 133 | $7,578 |
| Ozempic Semaglutide | 309 | 326 | 51 | $230K |
| Methimazole Generic | 160 | 516 | 60 | $3,721 |
| Insulin Glargine-Yfgn Generic | 160 | 436 | 63 | $27K |
| Humulin N Insulin Nph Human Isophane | 156 | 470 | 60 | $42K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 150 | 353 | 61 | $4,360 |
| Humulin N Kwikpen Insulin Nph Human Isophane | 142 | 351 | 50 | $36K |
| Alendronate Sodium Generic | 134 | 352 | 39 | $1,385 |
| Jardiance Empagliflozin | 100 | 293 | 35 | $58K |
| Humulin R Insulin Regular, Human | 97 | 264 | 40 | $19K |
| Humalog Insulin Lispro | 79 | 241 | 32 | $29K |
| Metformin Hcl Generic | 79 | 259 | 33 | $956 |
| Glipizide Generic | 78 | 236 | 29 | $1,049 |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 74 | 196 | 37 | $1,986 |
| Humalog Kwikpen U-100 Insulin Lispro | 64 | 154 | 28 | $24K |
Brand drugs: 1,386 claims; generic drugs: 1,390 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anjali Jain $221 ($221 in general payments such as food, travel and fees) from 1 company. The largest payer was Beta Bionics, Inc. with $221.
| Company | Payments | Amount |
|---|---|---|
| Beta Bionics, Inc. BBNX | 3 | $221 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.